Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III StudyRobert J. Motzer, Theodore Stewart Gourdin, Viktor Grünwald et al.|Journal of Clinical Oncology|2024Cited by 170
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapyBhavana Bhatnagar, Maria R. Baer, Vu H. Duong et al.|Leukemia & lymphoma/Leukemia and lymphoma|2013Cited by 56